Your browser doesn't support javascript.
loading
Overriding FUS autoregulation in mice triggers gain-of-toxic dysfunctions in RNA metabolism and autophagy-lysosome axis.
Ling, Shuo-Chien; Dastidar, Somasish Ghosh; Tokunaga, Seiya; Ho, Wan Yun; Lim, Kenneth; Ilieva, Hristelina; Parone, Philippe A; Tyan, Sheue-Houy; Tse, Tsemay M; Chang, Jer-Cherng; Platoshyn, Oleksandr; Bui, Ngoc B; Bui, Anh; Vetto, Anne; Sun, Shuying; McAlonis-Downes, Melissa; Han, Joo Seok; Swing, Debbie; Kapeli, Katannya; Yeo, Gene W; Tessarollo, Lino; Marsala, Martin; Shaw, Christopher E; Tucker-Kellogg, Greg; La Spada, Albert R; Lagier-Tourenne, Clotilde; Da Cruz, Sandrine; Cleveland, Don W.
Afiliación
  • Ling SC; Ludwig Institute for Cancer Research, University of California, San Diego, San Diego, United States.
  • Dastidar SG; Department of Cellular and Molecular Medicine, University of California, San Diego, San Diego, United States.
  • Tokunaga S; Department of Neurosciences, University of California, San Diego, San Diego, United States.
  • Ho WY; Department of Physiology, National University of Singapore, Singapore, Singapore.
  • Lim K; Neurobiology/Ageing Programme, National University of Singapore, Singapore, Singapore.
  • Ilieva H; Program in Neuroscience and Behavior Disorders, Duke-NUS Medical School, Singapore, Singapore.
  • Parone PA; Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, United States.
  • Tyan SH; Ludwig Institute for Cancer Research, University of California, San Diego, San Diego, United States.
  • Tse TM; Department of Physiology, National University of Singapore, Singapore, Singapore.
  • Chang JC; Department of Physiology, National University of Singapore, Singapore, Singapore.
  • Platoshyn O; Ludwig Institute for Cancer Research, University of California, San Diego, San Diego, United States.
  • Bui NB; Department of Cellular and Molecular Medicine, University of California, San Diego, San Diego, United States.
  • Bui A; Ludwig Institute for Cancer Research, University of California, San Diego, San Diego, United States.
  • Vetto A; Department of Cellular and Molecular Medicine, University of California, San Diego, San Diego, United States.
  • Sun S; Department of Neurosciences, University of California, San Diego, San Diego, United States.
  • McAlonis-Downes M; Department of Medicine, National University of Singapore, Singapore, Singapore.
  • Han JS; Department of Physiology, National University of Singapore, Singapore, Singapore.
  • Swing D; Ludwig Institute for Cancer Research, University of California, San Diego, San Diego, United States.
  • Kapeli K; Department of Anesthesiology, University of California, San Diego, San Diego, United States.
  • Yeo GW; Ludwig Institute for Cancer Research, University of California, San Diego, San Diego, United States.
  • Tessarollo L; Ludwig Institute for Cancer Research, University of California, San Diego, San Diego, United States.
  • Marsala M; Ludwig Institute for Cancer Research, University of California, San Diego, San Diego, United States.
  • Shaw CE; Ludwig Institute for Cancer Research, University of California, San Diego, San Diego, United States.
  • Tucker-Kellogg G; Department of Cellular and Molecular Medicine, University of California, San Diego, San Diego, United States.
  • La Spada AR; Ludwig Institute for Cancer Research, University of California, San Diego, San Diego, United States.
  • Lagier-Tourenne C; Department of Cellular and Molecular Medicine, University of California, San Diego, San Diego, United States.
  • Da Cruz S; Ludwig Institute for Cancer Research, University of California, San Diego, San Diego, United States.
  • Cleveland DW; Department of Cellular and Molecular Medicine, University of California, San Diego, San Diego, United States.
Elife ; 82019 02 12.
Article en En | MEDLINE | ID: mdl-30747709
ABSTRACT
Mutations in coding and non-coding regions of FUS cause amyotrophic lateral sclerosis (ALS). The latter mutations may exert toxicity by increasing FUS accumulation. We show here that broad expression within the nervous system of wild-type or either of two ALS-linked mutants of human FUS in mice produces progressive motor phenotypes accompanied by characteristic ALS-like pathology. FUS levels are autoregulated by a mechanism in which human FUS downregulates endogenous FUS at mRNA and protein levels. Increasing wild-type human FUS expression achieved by saturating this autoregulatory mechanism produces a rapidly progressive phenotype and dose-dependent lethality. Transcriptome analysis reveals mis-regulation of genes that are largely not observed upon FUS reduction. Likely mechanisms for FUS neurotoxicity include autophagy inhibition and defective RNA metabolism. Thus, our results reveal that overriding FUS autoregulation will trigger gain-of-function toxicity via altered autophagy-lysosome pathway and RNA metabolism function, highlighting a role for protein and RNA dyshomeostasis in FUS-mediated toxicity.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Autofagia / ARN / Proteína FUS de Unión a ARN / Homeostasis / Lisosomas Límite: Animals / Humans Idioma: En Revista: Elife Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Autofagia / ARN / Proteína FUS de Unión a ARN / Homeostasis / Lisosomas Límite: Animals / Humans Idioma: En Revista: Elife Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos